The Colon Cancer Information Center provides in-depth information on colon cancer, colorectal cancer and treatment with Camptosar® (irinotecan, also known as CPT-11). The colon cancer information is intended for use by both oncology professionals and patients in the United States.
|
|
|
|
|
|
Camptosar (irinotecan) Product Information For Health Care Professionals |
Product Announcement: New Clinical Data On Metastatic Colorectal Cancer- Product Overview: New survival Data On CAMPTOSAR In Metastatic Colorectal Cancer
- CAMPTOSAR - A Complete Product Monograph
- CAMPTOSAR Dosing Schedules And Treatment Options
- CAMPTOSAR - Management Of Side effects
- Patient Management Guidelines
- Phase II Trial of Irinotecan in Patients With Progressive or Rapidly Recurrent Colorectal Cancer
- News Release: 10/23/98, Full FDA Approval of CAMPTOSAR for Treatment of Colorectal Cancer
- CAMPTOSAR - Packing Information
- Contact Information: Pharmacia & Upjohn
|
|
Camptosar (Irinotecan) Product Information for Patients
|
- CAMPTOSAR - Question & Answer Guide
- CAMPTOSAR - A Treatment Guide For You
- CAMPTOSAR - What You Need To Know Before Your First Treatment With Camptosar
- Loperamide (Imodium A-D) Doses For Chemotherapy-Induced Diarrhea
- Diarrhea - An Overview
- Symptom Management - Important Information About Diarrhea
|
|
Full Prescribing Information |
©Copyright 1995-2012 Ultitech, Inc. All Rights Reserved.